abstract |
The present disclosure relates to Zika virus vaccines and immunogenic compositions having one or more antigens from a Zika virus ( e.g., a Zika virus clonal isolate, a non-human cell adapted Zika virus, etc. ), and methods of treatments and uses thereof. |